Abstract
Constitutive activation of AKT is a frequent occurrence in the development of human T-cell acute lymphocytic leukemia/lymphomas (T-ALLs), due largely to inactivation of PTEN. Up regulation of MYC is also commonly observed in human T-ALLs. We previously demonstrated that expression of a constitutively active form of Lck-Akt2 alone is sufficient to initiate T-cell lymphoma in mice, and that tumor formation typically requires up regulation of Myc or Dlx5 caused by specific chromosomal rearrangements. Furthermore, Lck-Dlx5 mice develop T-ALLs that consistently acquire overexpression of Myc and activation of Akt, the latter due to loss of Pten expression. Proliferation of T-ALL cells from Lck-Dlx5 mice was found to be highly sensitive to the Akt pathway inhibitors BEZ235 and RAD001, as well as to JQ1, an inhibitor of bromodomain proteins, one of which (BRD4) regulates Myc transcription. Additionally, low concentrations of BEZ235 were found to cooperate with JQ1 to enhance cell cycle arrest. Higher concentrations of BEZ235 (≥0.5 µM) promoted cell death, although the addition of JQ1 did not result in a further increase in apoptosis. In contrast, the specific Myc inhibitor 10058-F4 caused apoptosis, and when combined with BEZ235 (≥0.5 ...Continue Reading
References
Jun 26, 1992·Cell·J ChungJ Blenis
Jan 11, 1991·Science·G C Prendergast, E B Ziff
Mar 8, 1991·Science·E M Blackwood, R N Eisenman
Jun 30, 1994·Nature·E J BrownS L Schreiber
Apr 22, 2000·Oncogene·B RudolphG I Evan
Mar 29, 2001·Nature Immunology·N C DouglasA C Hayday
Feb 8, 2003·Science·David M LangenauA Thomas Look
Jul 19, 2006·Genes & Development·Andrew P WengJon C Aster
Oct 19, 2006·Experimental Hematology·Ming-Jer HuangH Eugene Liu
Jul 25, 2007·The Journal of Experimental Medicine·Jennifer O'NeilA Thomas Look
Mar 5, 2008·Cancer Research·Yinfei TanJoseph R Testa
May 30, 2008·Cancer Chemotherapy and Pharmacology·Jianxia GuoJulie L Eiseman
Jul 30, 2008·Blood·Thomas KindlerD Gary Gilliland
Sep 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Teresa Palomero, Adolfo Ferrando
Oct 3, 2008·Cancer Research·Violeta SerraJosé Baselga
Apr 9, 2009·Cancer Research·Francesca ChiariniAlberto M Martelli
Jun 6, 2009·The Journal of Biological Chemistry·Jinfei Xu, Joseph R Testa
Jun 17, 2009·Genes, Chromosomes & Cancer·Roman A TimakhovJoseph R Testa
Dec 17, 2009·Blood·Takaomi SandaA Thomas Look
Jun 22, 2010·Oncogene·J XiongZ Liang
Sep 28, 2010·Nature·Panagis FilippakopoulosJames E Bradner
Nov 4, 2010·Cancer Research·Yinfei TanJoseph R Testa
Mar 26, 2013·Lancet·Hiroto InabaCharles G Mullighan
Jan 8, 2014·Blood·Justine E RoderickMichelle A Kelliher
Sep 23, 2014·Seminars in Cell & Developmental Biology·Kezhen Huang, Diane C Fingar
Citations
May 28, 2015·Current Hematologic Malignancy Reports·Carla Casulo, Jonathan Friedberg
Jul 7, 2015·Trends in Biochemical Sciences·Chen-Yi Wang, Panagis Filippakopoulos
Apr 1, 2017·Genes·Himalee S SabnisKevin D Bunting
Feb 9, 2020·International Journal of Molecular Sciences·Chiara TarantelliFrancesco Bertoni
Jan 26, 2017·Oncotarget·Yinfei TanJoseph R Testa
Oct 17, 2015·Oncotarget·Qiaoli ZhaoThomas Efferth
Sep 8, 2020·Future Medicinal Chemistry·Yifei YangJinpei Zhou
Aug 16, 2019·Cancer Investigation·Niknam RiyahiDavood Bashash
Jul 14, 2016·Molecular Cancer Therapeutics·Simon J HoggRicky W Johnstone
Nov 27, 2019·European Journal of Pharmacology·Negar Sheikh-ZeineddiniDavood Bashash
Jun 2, 2021·Frontiers in Endocrinology·Jie ZhangXiong Zhang
Jul 3, 2021·Cancers·Yinfei Tan, Joseph R Testa